Management of Carvedilol Before Transesophageal Echocardiography

Rationale for Continuing Carvedilol

The American Society of Anesthesiologists recommends that TEE is considered a low-bleeding risk procedure that can be safely performed while maintaining therapeutic cardiovascular medications, including beta-blockers like carvedilol 1
Abrupt discontinuation of beta-blockers like carvedilol may lead to rebound tachycardia, hypertension, or worsening of underlying cardiac conditions, potentially increasing procedural risks 1
For patients undergoing TEE-guided cardioversion, maintaining hemodynamic stability is particularly important, and continuing beta-blocker therapy helps achieve this goal 2, 3

For patients undergoing TEE-guided cardioversion for atrial fibrillation, maintaining hemodynamic stability is crucial, and beta-blockers like carvedilol help control ventricular rate and maintain hemodynamic stability during the procedure 2, 3
The European Society of Cardiology suggests that in cases of hemodynamic instability requiring immediate cardioversion after TEE, rate control medications including beta-blockers are particularly important 2

The American Society of Anesthesiologists recommends that for diagnostic TEE procedures, continuing carvedilol helps maintain stable hemodynamics during the procedure 4
The American Heart Association suggests that when TEE is used to assess ventricular function, continuing carvedilol provides a more accurate representation of the patient's typical hemodynamic state 5

In extremely rare cases where a patient has severe bradycardia or hypotension that could be exacerbated by carvedilol, individual risk assessment may be warranted, as recommended by the American Society of Anesthesiologists 4
If TEE reveals unexpected severe hemodynamic compromise during the procedure, management of beta-blocker therapy may need to be reassessed, according to the American Society of Anesthesiologists 4